Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis [PDF]
Meredith Y. Smith +6 more
openalex +1 more source
Safety Assessment of High‐ and Low‐Molecular‐Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data [PDF]
Daniel Cassuto +5 more
openalex +1 more source
Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52‐week analysis of a postmarketing surveillance study in Japan [PDF]
Nobukazu Hayashi +7 more
openalex +1 more source
Incentivizing Postmarketing Pharmaceutical Product Safety Testing with Extension of Exclusivity Periods [PDF]
Kushner, Leslie
core +1 more source
Controversial efficacy of antithrombin followed by recombinant thrombomodulin administration in patients with sepsis-induced disseminated intravascular coagulation: an analysis of postmarketing surveillance data. [PDF]
Eguchi Y, Nagafuchi H, Ikeda T.
europepmc +1 more source
Policy Without Penalty: A Review of Pediatric Research Equity Act Noncompliance Letters. [PDF]
Green DJ +3 more
europepmc +1 more source
An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: methodology [PDF]
Ardissino, Gianluigi +10 more
core
Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence. [PDF]
Dong Y +9 more
europepmc +1 more source

